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Abstract: Numerous symptoms and complications of COVID-19 include pneumothorax as a rare but potentially-lethal
condition. The present case report involved a pregnant woman with COVID-19 presenting with pneumothorax.
A 30-year-old pregnant woman with COVID-19 and a gestational age of 32 weeks presented to our hospital with
dyspnea, coughs and fever. The rales initially heard in both lungs continued to be heard only in the left lung after
24 hours. Pneumothorax was confirmed through radiology. The emergency cesarean section performed to avoid
the potential detrimental effects of the infection on the fetus caused no breathing episodes in the biophysical
profile. The patient recovered postpartum without complications and both the mother and the newborn were
discharged 12 days later. Spontaneous pneumothorax is a rare complication in COVID-19 pregnant patients that
can emerge at any stage of the disease.
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1. Introduction
An outbreak of an unexplained pneumonia was reported in
China in late December 2019. Examining the samples taken
from the lower respiratory tract revealed an unknown dis-
ease, which was then named COVID-19 by the World Health
Organization (WHO) (1). Pregnant women are at high risks
for severe COVID-19 and its adverse pregnancy outcomes
(2, 3). COVID-19 caused intensive care unit (ICU) admis-
sion in 16% of pregnant women, mechanical ventilation in
8% and death in 1% (4). Hollingshead and Hanrahan pio-
neered the reporting of pneumothorax as a complication of
COVID-19 one month after treating a patient (5). The overall
incidence of spontaneous pneumothorax was reported as 1%
(6). However, the incidence of this complication in pregnant
women is much rarer. The present case report involved a
pregnant patient with COVID-19 who developed pneumoth-
orax during her hospital stay. The presentation was provided
after asking the patient to announce her consent and was
approved by the Ethics Committee of Jahrom University of
Medical Sciences (IR.JUMS.REC.1400.001). Written informed
consent was obtained from the patient for publishing this
case report and any accompanying images.
2. Case presentation
This report focused on a 30-year-old woman, G2L0D1, with
a gestational age of 32 weeks, 8-year history of secondary
infertility and no history of systemic or autoimmune disease
other than diet-controlled gestational diabetes mellitus. The
patient became pregnant after losing her 9-year-old child
duo to a car accident. She suffered from fever, body aches,
coughs and shortness of breath 5 days prior to admission.
Her reverse transcription polymerase chain reaction (RT-
PCR) test was found positive for SARS-CoV-2 after presenting
to a hospital near her place of residence. She was then imme-
diately referred with dyspnea and nausea to the emergency
department (ED) of a COVID-19 specialized hospital in
Jahrom, Iran. Her vital signs were measured upon admission
as follows: blood pressure: 117/81 mmHg, pulse rate: 104
beats/min, respiratory rate: 20/min, oral temperature: 37°C,
O2 saturation in room air: 86%.
Her lung examinations showed fine bilateral rales, which
were more intense on the right side. According to national
guidelines at the time of patient admission, she was pre-
scribed with atazanavir, azithromycin, dexamethasone,
atorvastatin, enoxaparin, zinc, famotidine, vitamin C, vita-
min D3 and oxygen via masks as needed. High-resolution
computed tomography (HRCT) was not, however, performed
due to her pregnancy and the patient’s unwillingness. Moni-
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Figure 1 A) Coronal and B) axial sections of low dose HRCT taken after the chest x-ray to confirm the diagnosis and follow up for other
potential complications. The chest X-ray showed diffuse and bilateral consolidation, pneumonia and pneumothorax on the right side, which
caused the collapse of the right lung C). Lower lobe predominant ground-glass opacities caused by COVID-19
toring the fetal status showed 6 accelerations in 20 minutes
in the non-stress test (NST), a biophysical profile score of
8/8 and an amniotic fluid index (AFI) of 18 cm.
Deterioration of the patient’s general health on her admis-
sion day caused the establishment of a care committee
comprising a pediatrician, an obstetrician/gynecologist, an
infectiologist, an internist, a cardiologist, a radiologist and a
psychiatrist. This committee was in charge of declaring the
need for termination of pregnancy and ordering diagnostic
imaging modalities especially HRCT. On 2nd day of admis-
sion, a sudden shortness of breath and a sharp and sudden
chest pain were observed in the patient. The rales heard in
both lungs continued to be heard only in the left lung after a
while. The low-dose HRCT ultimately performed confirmed
pneumothorax (Figure 1), which deteriorated the patient’s
status. Thereafter, tube thoracostomy was performed,
and the patient was transferred to ICU. One gram of van-
comycin was also prescribed every 12 hours and 1 gram of
meropenem every 8 hours, given the generally-poor health
status and pneumonia of the patient. She was provided
with an oxygen mask rather than undergoing mechanical
ventilation. The NST and blood sugar measurement were
performed on a daily basis. Insulin was administered due to
pregnancy-induced hyperglycemia. Psychiatric counseling
was also performed to improve the emotional status of the
patient.
on the 2nd day of admission to the ICU, due to decreased
fetal activity, NST repeated after hydration that showed fatal
tachycardia, negative beat-to-beat variability and no accel-
eration. The biophysical profile also suggested fine limb
movements, no breathing and a score of 6/8. A renewed lung
HRCT scan was performed (Figure 2), enoxaparin discon-
tinued and the patient underwent an emergency cesarean
section to terminate her pregnancy at the discretion of the
care committee. Cesarean section was performed under
spinal anesthesia with vertical and transverse incisions
made on the abdominal wall and the uterus, respectively.
The preterm infant in transverse lie born at the gestational
age of 32 weeks was then transferred to the neonatal inten-
sive care unit (NICU). Although the RT-PCR was negative for
COVID-19 in the neonate, she was isolated from her mother
throughout the hospitalization.
Twelve hours after the operation, enoxaparin and remdesivir
Figure 2 HRCT was performed before cesarean section and after
tube thoracostomy to help manage the patient during her opera-
tion. The intervention caused subcutaneous emphysema around the
chest tube
Figure 3 Chest X-ray; this modality was taken three hours after
clamping the chest tube. The chest tube was later removed as there
was no further evidence for air in the chest. The posteroanterior view
showed trachea in the midline and no mediastinal rotation and con-
solidation in the lung parenchyma
were administered based on national guidelines. Remdesivir
and vancomycin were discontinued with the improvement
in the patient’s general condition two days after her cesarean
section. Moreover, a chest x-ray was performed three hours
after clamping the chest tube, which was removed after 4
days (Figure 3). The patient was then transferred to the
ward to regulate her blood sugar. Despite lower daily needs
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for insulin after the cesarean section, NPH insulin was
administered until the patient was discharged. After 12 days
of ICU admission, the patient was discharged with a proper
general health and prescribed with olanzapine, sertraline,
enoxaparin, famotidine, prednisolone and insulin. The
neonate was also discharged in normal conditions four days
after her birth.
3. Discussion
COVID-19 is a respiratory disease involving the lower res-
piratory tract, most often caused by close contact with an
infected person (7). Pregnant women are at risk, and the
number of cases is constantly growing (2, 8). Physiological
changes such as elevated hemidiaphragm, increased oxygen
consumption and inflammation of the mucous membranes
of the respiratory tract increase the vulnerability of pregnant
women to respiratory diseases, including pneumonia (3, 9).
Although pregnant women are not immune-compromised in
the classical sense, their immunologic changes increase their
vulnerability to intracellular pathogens, especially viruses
such as severe acute respiratory syndrome (SARS) (10).
The outcomes in the second and third trimester of preg-
nancy have rarely been addressed in literature; nevertheless,
preterm premature rupture of membranes, preterm labor,
fetal distress, and intrauterine fetal death were reported in
pregnant women with COVID-19 (2, 11). Other complica-
tions include different types of organ dysfunction, shocks,
acute respiratory distress syndrome (ARDS), arrhythmia and
thrombosis as well as spontaneous pneumothorax in rare
cases were also reported (11-14). Research suggests a preva-
lence of 1%-2% for pneumothorax in patients with COVID-
19 (15). Alveolar rupture was reported as the cause of pneu-
mothorax despite its yet-unknown relationships with SARS-
CoV-2 and inadequate evidence for its mechanism and phys-
iopathology (14, 16). This complication can rapidly progress
and even cause death. Early diagnosis of this disease and its
continuous monitoring are therefore crucial for a successful
treatment.
Early diagnosis of COVID-19 mainly through laboratory tests
such as RT-PCR and lung CT scan and appropriate treat-
ments are crucial for reducing its complications and mortal-
ity (11). In pregnant women according to guidelines, the final
diagnosis of COVID-19 is a nasal and throat swab for RT-PCR.
Also, low dose CT-scan can be used as a screening test be-
cause the dosages are relatively safe during pregnancy when
abdominal shielding is used. Although this radiation is low
enough not to be harmful for the fetus, especially when pro-
tected by a lead protection; Albeit, the exposure of breast tis-
sue to radiation can still be harmful and may increase breast
cancer risk in the future (17-21). On the other hand, failing
to accurately diagnose the disease in time most likely causes
dire consequences.
Performing appropriate management and follow-up had re-
covered several pregnant women with COVID-19 in the hos-
pital. This experience helped adopt optimal strategies in
the face of the emerging complication of COVID-19 and ul-
timately save both the mother and her neonate despite high
stress levels in the woman and the birth of the premature
baby.
4. Conclusion
Spontaneous pneumothorax is a rare complication in
COVID-19 pregnant patients that can emerge at any stage of
the disease. Given the rapid and terminal course of this com-
plication, its early diagnosis is vital for providing adequate
care and treatment for the patients.
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